Foley Hoag Attorneys to Provide Insight to Korean Companies Entering the US Healthcare Marketplace

June 19, 2014

Foley Hoag Partner Thomas Barker, former General Counsel at the U.S. Department of Health and Human Services (HHS), and Associate Maia Larsson will present “Key Strategies for Korean Pharmaceutical and Biopharmaceutical Companies Entering and Expanding Into the U.S. Healthcare Marketplace” during the 2014 BIO International Convention in San Diego.  

Speaking to an audience consisting of Korean life sciences executives, Barker and Larsson will outline the importance of developing strategies to position a Korean pharmaceutical company favorably in the U.S. market. Focus will be placed on how to formulate effective Medicare and Medicaid coverage and reimbursement strategies; a basic review of the U.S. FDA regulatory framework; and key points related to compliance and new reporting rules applicable to pharmaceutical manufacturers.  The presentation will also address factors in determining whether a product will be covered and paid for by the Medicare and Medicaid programs, and the impact this could have on the product’s success in the rest of the U.S. healthcare market.

Key Contacts